BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27860499)

  • 21. A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit.
    Grainger A; Eiden K; Kemper J; Reeds D
    Nutr Clin Pract; 2007 Oct; 22(5):545-52. PubMed ID: 17906278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.
    Gracia-Ramos AE; Cruz-Dominguez MDP; Madrigal-Santillán EO; Rojas-Martínez R; Morales-González JA; Morales-González Á; Hernández-Espinoza M; Vargas-Peñafiel J; Tapia-González MLÁ
    J Diabetes Complications; 2024 May; 38(5):108742. PubMed ID: 38581842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detemir vs Glargine: Comparison of Inpatient Glycemic Control.
    Capson J; Cade K; Avanesyan A
    J Am Osteopath Assoc; 2019 Feb; 119(2):89-95. PubMed ID: 30688354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premixed insulin treatment for type 2 diabetes: analogue or human?
    Garber AJ; Ligthelm R; Christiansen JS; Liebl A
    Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching from premixed human insulin to premixed insulin lispro: a prospective study comparing the effects on glucose control and quality of life.
    Yamada S; Watanabe M; Kitaoka A; Shiono K; Atsuda K; Tsukamoto Y; Kawana Y; Irie J
    Intern Med; 2007; 46(18):1513-7. PubMed ID: 17878636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humalog (lispro) for type 2 diabetes.
    Esposito K; Capuano A; Giugliano D
    Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?
    Giugliano D; Sieradzki J; Stefanski A; Gentilella R
    Curr Med Res Opin; 2016 Aug; 32(8):1425-34. PubMed ID: 27126277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
    Umpierrez GE; Smiley D; Jacobs S; Peng L; Temponi A; Mulligan P; Umpierrez D; Newton C; Olson D; Rizzo M
    Diabetes Care; 2011 Feb; 34(2):256-61. PubMed ID: 21228246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial).
    Kuchay MS; Khatana P; Mishra M; Surendran P; Kaur P; Wasir JS; Gill HK; Singh A; Jain R; Kohli C; Bakshi G; Radhika V; Saheer S; Singh MK; Mishra SK
    Acta Diabetol; 2023 Nov; 60(11):1481-1490. PubMed ID: 37380728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial.
    Olveira G; Abuín J; López R; Herranz S; García-Almeida JM; García-Malpartida K; Ferrer M; Cancer E; Luengo-Pérez LM; Álvarez J; Aragón C; Ocón MJ; García-Manzanares Á; Bretón I; Serrano-Aguayo P; Pérez-Ferre N; López-Gómez JJ; Olivares J; Arraiza C; Tejera C; Martín JD; García S; Abad ÁL; Alhambra MR; Zugasti A; Parra J; Torrejón S; Tapia MJ
    Clin Nutr; 2020 Feb; 39(2):388-394. PubMed ID: 30930133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of race/ethnicity on efficacy and safety of two starter insulin regimens in patients with type 2 diabetes: a posthoc analysis of the DURABLE trial.
    Davidson JA; Wolffenbuttel BH; Arakaki RF; Caballero AE; Jiang HH; Hardin DS
    Ethn Dis; 2013; 23(4):393-400. PubMed ID: 24392599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inpatient Glycemic Control With Sliding Scale Insulin in Noncritical Patients With Type 2 Diabetes: Who Can Slide?
    Migdal AL; Fortin-Leung C; Pasquel F; Wang H; Peng L; Umpierrez GE
    J Hosp Med; 2021 Aug; 16(8):462-468. PubMed ID: 34328842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical efficacy and safety of basal insulin analogue glargine in patients with type 2 diabetes mellitus].
    Flekač M; Šoupal J
    Vnitr Lek; 2016; 62(9):705-711. PubMed ID: 27715072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis.
    Christensen MB; Gotfredsen A; Nørgaard K
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28067472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin Regimens to Treat Hyperglycemia in Hospitalized Patients on Nutritional Support: Systematic Review and Meta-Analyses.
    Verçoza Viana M; Verçoza Viana L; Tavares AL; de Azevedo MJ
    Ann Nutr Metab; 2017; 71(3-4):183-194. PubMed ID: 29017173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influencing factors of glycemic variability in hospitalized type 2 diabetes patients with insulin therapy: A Strobe-compliant article.
    Huang Y; Heng C; Wei J; Jing X; Wang X; Zhao G; Hou J; Liu Q; Jiao K
    Medicine (Baltimore); 2017 Sep; 96(36):e8021. PubMed ID: 28885369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards.
    Neubauer KM; Mader JK; Höll B; Aberer F; Donsa K; Augustin T; Schaupp L; Spat S; Beck P; Fruhwald FM; Schnedl C; Rosenkranz AR; Lumenta DB; Kamolz LP; Plank J; Pieber TR
    Diabetes Technol Ther; 2015 Oct; 17(10):685-92. PubMed ID: 26355756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. InsulinAPP application protocol for the inpatient management of type 2 diabetes on a hospitalist-managed ward: a retrospective study.
    Toyoshima MTK; Brandes PHR; da Paz Lauterbach G; Moraes JRA; de Paiva EF; Umpierrez GE; Nery M; Kondo RH
    Arch Endocrinol Metab; 2022 Sept 08; 66(4):498-505. PubMed ID: 35758838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic control with regular versus lispro insulin sliding scales in hospitalized Type 2 diabetics.
    Alfonso A; Koops MK; Mong DP; Vigersky RA
    J Diabetes Complications; 2006; 20(3):153-7. PubMed ID: 16632234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy.
    Watada H; Ross Agner BF; Doshi A; Bardtrum L; Ranthe MF; Billings LK
    Diabetes Ther; 2020 Jan; 11(1):331-339. PubMed ID: 31760599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.